Skip to content

Oncolytics Biotech Inc.

ONCY Nasdaq SEC CIK 1129928

Follow Oncolytics Biotech Weekly email: filings, results, news

News

1 story filed under Oncolytics Biotech

Oncolytics Biotech® Aligns with FDA on Registrational Path for Second-Line RAS-Mutant MSS Colorectal Cancer

Markets 37 d ago also on MSS

Profile

Headquarters: SAN DIEGO, CA, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

News · 1 story clustered from the RSS aggregator